Measuring plasma C4D to monitor immune complexes in lupus nephritis

Objective Because currently available assays that measure circulating immune complexes (ICx) are suboptimal, a novel assay was recently developed measuring C4d, a stable product of activation of the classical complement pathway. The present study aimed to establish the value of measuring plasma C4d levels in a longitudinal cohort of patients with severe refractory SLE who were treated with a combination therapy of rituximab with belimumab (RTX+BLM). Methods Fifteen patients with SLE who were treated with RTX+BLM in a phase 2A, open label study were included to sequentially measure plasma C4d levels and correlated to well-established markers of ICx-formation, that is, autoantibodies against double-stranded (ds) DNA, autoantibodies against C1q and proteinuria. The performance of plasma C4d measurements, C4 measurements and the ratio of C4d over C4 (C4d:C4) was evaluated. Results After establishing that on RTX+BLM treatment kinetics of C4d levels was distinct from traditional C3 and C4 levels, we found strong correlation of C4d:C4 with anti-dsDNA (R=0.76, p<0.001) and anti-C1q (R=0.65, p<0.001) autoantibody levels, which outperformed both stand-alone C4 and C4d levels. Additionally, changes in C4d:C4 over time correlated strongly with changes in proteinuria (R=0.59, p<0.001) as well as anti-dsDNA (R=0.46, p=0.003) and anti-C1q (R=0.47, p=0.002). Conclusion In patients with severe SLE, plasma C4d levels in relation to C4 levels is useful for longitudinal monitoring after RTX+BLM treatment to reflect amelioration of classical complement activation by ICx as well as proteinuria.

[1]  T. Rabelink,et al.  FRI0330 Rituximab therapy in sle: early retreatment is associated with lower disease activity and a reduction in corticosteroid use , 2018, Journal of autoimmunity.

[2]  A. Blom,et al.  Plasma C4d as marker for lupus nephritis in systemic lupus erythematosus , 2017, Arthritis Research & Therapy.

[3]  Ron Wolterbeek,et al.  Clinical and Histopathologic Characteristics Associated with Renal Outcomes in Lupus Nephritis. , 2017, Clinical journal of the American Society of Nephrology : CJASN.

[4]  A. Blom,et al.  Antibodies reactive to cleaved sites in complement proteins enable highly specific measurement of soluble markers of complement activation. , 2015, Molecular immunology.

[5]  M. Wener.  Tests for circulating immune complexes. , 2014, Methods in molecular biology.

[6]  K. Kalunian,et al.  Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus. , 2012, Arthritis and rheumatism.

[7]  J. Ahearn,et al.  Prospective assessment of C4d deposits on circulating cells and renal tissues in lupus nephritis: a pilot study , 2012, Lupus.

[8]  J. Berden,et al.  Lupus nephritis: role of antinucleosome autoantibodies. , 2011, Seminars in nephrology.

[9]  Min Chen,et al.  The complement system in systemic autoimmune disease. , 2010, Journal of autoimmunity.

[10]  J. Ahearn,et al.  Erythrocyte C3d and C4d for monitoring disease activity in systemic lupus erythematosus. , 2010, Arthritis and rheumatism.

[11]  J. Ahearn,et al.  Reticulocytes bearing C4d as biomarkers of disease activity for systemic lupus erythematosus. , 2005, Arthritis and rheumatism.

[12]  S. Sereika,et al.  Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity. , 1996, Arthritis and rheumatism.

[13]  S. Abramson,et al.  Assessment of disease activity and impending flare in patients with systemic lupus erythematosus. Comparison of the use of complement split products and conventional measurements of complement. , 1992, Arthritis and rheumatism.

[14]  A. Cats,et al.  The value of complement and immune complex determinations in monitoring disease activity in patients with systemic lupus erythematosus. , 1985, Arthritis and rheumatism.

[15]  Z. Bentwich,et al.  Use and Abuse of Laboratory Tests in Clinical Immunology: Critical Considerations of Eight Widely Used Diagnostic Procedures , 1982 .

[16]  Use and abuse of laboratory tests in clinical immunology: critical considerations of eight widely used diagnostic procedures. Report of a joint IUIS/WHO meeting on assessment of tests used in clinical immunology. , 1982, Clinical immunology and immunopathology.